Morbilliform rashes in a patient with COVID-19 infection: A case report

As the current COVID-19 pandemic is evolving, skin lesions are being reported more, the most common skin manifestation being morbilliform rashes. We describe a patient of severe COVID-19 infection, 48-year-old who initially presented with fever, cough and constitutional symptoms who developed morbi...

Full description

Bibliographic Details
Main Authors: Kiran Ghimire, Nabin Adhikari
Format: Article
Language:English
Published: Nepal Medical Association 2021-04-01
Series:Journal of Nepal Medical Association
Subjects:
Online Access:http://www.jnma.com.np/jnma/index.php/jnma/article/view/5128
id doaj-4d3f969e944a44a5a40b5b6edb2c6a21
record_format Article
spelling doaj-4d3f969e944a44a5a40b5b6edb2c6a212021-05-16T10:32:35ZengNepal Medical AssociationJournal of Nepal Medical Association0028-27151815-672X2021-04-015923610.31729/jnma.5128Morbilliform rashes in a patient with COVID-19 infection: A case report Kiran Ghimire0Nabin Adhikari1Shree Birendra Hospital, Chhauni, Kathmandu, NepalShree Birendra Hospital, Chhauni, Kathmandu, Nepal. As the current COVID-19 pandemic is evolving, skin lesions are being reported more, the most common skin manifestation being morbilliform rashes. We describe a patient of severe COVID-19 infection, 48-year-old who initially presented with fever, cough and constitutional symptoms who developed morbilliform macular rashes during his illness. The rash appeared on 6th day of illness in the trunk, arms with sparing of palms and soles, associated with itching. He later developed features of the cytokine-storm syndrome. The exact mechanism for the rashes is yet to be elaborated, however, it is postulated that it is either due to immune-mediated vasodilation or micro thrombosis secondary to low-grade-coagulopathy associated with COVID-19. Recognition of rashes as a feature of this disease is particularly significant to clinicians as it aids in early diagnosis, particularly in resource-poor countries. There is no evident association, however, between the severity and the rashes in COVID-19 infection. http://www.jnma.com.np/jnma/index.php/jnma/article/view/5128coagulopathy; COVID-19; cytokine release syndrome; D-dimer; morbilliform.
collection DOAJ
language English
format Article
sources DOAJ
author Kiran Ghimire
Nabin Adhikari
spellingShingle Kiran Ghimire
Nabin Adhikari
Morbilliform rashes in a patient with COVID-19 infection: A case report
Journal of Nepal Medical Association
coagulopathy; COVID-19; cytokine release syndrome; D-dimer; morbilliform.
author_facet Kiran Ghimire
Nabin Adhikari
author_sort Kiran Ghimire
title Morbilliform rashes in a patient with COVID-19 infection: A case report
title_short Morbilliform rashes in a patient with COVID-19 infection: A case report
title_full Morbilliform rashes in a patient with COVID-19 infection: A case report
title_fullStr Morbilliform rashes in a patient with COVID-19 infection: A case report
title_full_unstemmed Morbilliform rashes in a patient with COVID-19 infection: A case report
title_sort morbilliform rashes in a patient with covid-19 infection: a case report
publisher Nepal Medical Association
series Journal of Nepal Medical Association
issn 0028-2715
1815-672X
publishDate 2021-04-01
description As the current COVID-19 pandemic is evolving, skin lesions are being reported more, the most common skin manifestation being morbilliform rashes. We describe a patient of severe COVID-19 infection, 48-year-old who initially presented with fever, cough and constitutional symptoms who developed morbilliform macular rashes during his illness. The rash appeared on 6th day of illness in the trunk, arms with sparing of palms and soles, associated with itching. He later developed features of the cytokine-storm syndrome. The exact mechanism for the rashes is yet to be elaborated, however, it is postulated that it is either due to immune-mediated vasodilation or micro thrombosis secondary to low-grade-coagulopathy associated with COVID-19. Recognition of rashes as a feature of this disease is particularly significant to clinicians as it aids in early diagnosis, particularly in resource-poor countries. There is no evident association, however, between the severity and the rashes in COVID-19 infection.
topic coagulopathy; COVID-19; cytokine release syndrome; D-dimer; morbilliform.
url http://www.jnma.com.np/jnma/index.php/jnma/article/view/5128
work_keys_str_mv AT kiranghimire morbilliformrashesinapatientwithcovid19infectionacasereport
AT nabinadhikari morbilliformrashesinapatientwithcovid19infectionacasereport
_version_ 1721439908371890176